Why timing follows a pattern
GLP-1 side effects are closely tied to titration — most side effects cluster around starting treatment and each subsequent dose increase, then ease as your body adjusts before the next increase. Understanding this general pattern can help you distinguish expected, temporary symptoms from ones worth flagging. This is a general pattern, not a guarantee — individual experience varies significantly, including fast and slow responders.
Starting dose (first 2-4 weeks)
This is typically when nausea is most noticeable, alongside early appetite changes. Some people have minimal symptoms at the starting dose; others find this the hardest adjustment period. Injection site reactions are also most common early on, before technique and site rotation become routine.
Each dose increase (first few days to ~2 weeks after)
Expect a similar, sometimes more pronounced, wave of GI symptoms after each increase — nausea, possible vomiting, and changes in bowel habits (constipation or diarrhea). Fatigue often peaks in this window too. This is the pattern behind the standard titration schedule: gradual increases specifically to keep this wave manageable rather than overwhelming.
Between increases, once adjusted
Symptoms typically ease significantly between dose increases as your body adapts — many people report feeling "normal," just with a much smaller appetite, during these stretches. Constipation tends to be the most persistent symptom overall, sometimes continuing at a low level throughout treatment rather than fully resolving like nausea often does.
Longer-term (months into treatment)
By this stage, most people have settled into a stable pattern of symptoms, or minimal ongoing symptoms, at their maintenance dose. This is also when longer-latency effects can start to appear — hair loss (often 2-4 months after a period of rapid weight loss) and visible skin/facial changes (see our guide on GLP-1 face) are more likely to show up in this window than in the first few weeks.
Ongoing risks that don't follow a predictable timeline
Some risks — gallbladder disease, pancreatitis, and mood changes (see our guide on mood changes and anhedonia) — don't follow a clean titration-linked timeline and can emerge at any point in treatment. These are worth staying alert to throughout, not just during the early adjustment period.
The bottom line
Most GLP-1 side effects cluster predictably around treatment start and each dose increase, then ease before the next step — knowing this general rhythm can help you tell "expected adjustment" from "worth a call to my prescriber," covered in more detail in our guide on talking to your doctor about side effects that aren't improving.